Table 3 Distribution of COVID-19 Reporting and Data System CO-RADS (CO-RADS) scale, Total severity score (TSS), and CT findings
Variables | Data |
|---|---|
CO-RADS, n (%) | |
0 | 1 (0.4%) |
1 | 185 (73.1%) |
2 | 53 (20.9%) |
3 | 14 (5.5%) |
Total severity score, n (%) | |
0 | 227 (89.7%) |
1 | 5 (2.0%) |
2 | 5 (2.0%) |
3 | 5 (2.0%) |
4 | 6 (2.4%) |
5 | 3 (1.2%) |
≥ 6 | 2 (0.8%) |
Parenchymal involvement, n (%) | |
Bilateral involvement | 13 (5.1%) |
Unilateral involvement | 14 (5.5%) |
Multilobar involvement | 9 (3.6%) |
Distribution region, n (%) | |
Peripheral distribution | 9 (3.6%) |
Posterior distribution | 4 (1.6%) |
Central distribution | 4 (1.6%) |
Localization of the distribution, n (%) | |
Upper | 5 (2.0%) |
Middle | 6 (2.4%) |
Lower | 16 (6.3%) |
Diffuse | 8 (3.2%) |
Parenchymal state, n (%) | |
Consolidation | 16 (6.3%) |
Ground-glass opacification | 7 (2.8%) |
Crazy paving | 2 (0.8%) |
Other CT findings, n (%) | |
Pleural effusion | 18 (7.1%) |
Mediastinal lymphadenopathy | 4 (1.6%) |